Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News CareDx Inc CDNA

Healthcare Biotechnology
CareDx, Inc. is a precision medicine solutions company. The Company is focused on the discovery, development, and commercialization of clinically differentiated, diagnostic solutions for transplant patients and caregivers. The Company offers testing services, products, and patient and digital solutions along the pre- and post-transplant patient journey and is a provider of genomics-based... see more

Recent & Breaking News (NDAQ:CDNA)

CareDx Showcases Latest Innovation in Transplantation at European EFI 2022 Conference

GlobeNewswire May 11, 2022

CareDx Reports First Quarter 2022 Results

GlobeNewswire May 5, 2022

CareDx Validates Clinical Performance of AlloMap Kidney to Comprehensively Assess Transplant Rejection

GlobeNewswire May 5, 2022

CareDx Congratulates Board Member Dr. Hannah Valantine on ISHLT Lifetime Achievement Award

GlobeNewswire April 28, 2022

CareDx Extends Artificial Intelligence Leadership to Heart Transplantation

GlobeNewswire April 28, 2022

CareDx to Report First Quarter 2022 Financial Results

GlobeNewswire April 27, 2022

International Society for Heart and Lung Transplantation Foundation Selects Reg Seeto as Corporate Chair

GlobeNewswire April 27, 2022

CareDx Demonstrates Potential of AlloHeme and AlloCell for Allogeneic Cell Transplant and Therapy Monitoring at Transplantation & Cellular Therapy Meetings

GlobeNewswire April 22, 2022

CareDx Supports UC Davis Health Pluralist Program Aimed at Reducing Health Disparities in Organ Transplantation

GlobeNewswire April 21, 2022

CareDx Showcases Leadership with Over 25 Oral Presentations and Posters at the International Society for Heart and Lung Transplantation Meeting

GlobeNewswire April 20, 2022

CareDx Shareholder Notice

Newsfile April 14, 2022

CareDx Reports Over 200,000 Heart Transplant Patient Results Served

GlobeNewswire April 14, 2022

CareDx, the Leading Sponsor of UNOS Transplant Management Forum, Demonstrates the Value of Digital Solutions to Improve Pre-Transplant Patient Referral and Waitlisting Workflow

GlobeNewswire April 11, 2022

CareDx Update

Newsfile April 10, 2022

CareDx Shareholder Notice

Newsfile April 7, 2022

CareDx to Host Symposium at CEoT Featuring the Latest Multimodality Innovations in Kidney and Lung Transplant Surveillance

GlobeNewswire April 6, 2022

CareDx Shareholder Alert

Newsfile April 3, 2022

CareDx Investor Alert

Newsfile March 31, 2022

CareDx Partners with the European Society for Organ Transplantation to Provide Clinical Evidence Supporting the Use of AlloSeq cfDNA with European Transplant Healthcare Professionals

GlobeNewswire March 30, 2022

CareDx Partners with HeartBrothers Foundation to Help Patients Living with Heart Failure and Heart Transplant

GlobeNewswire March 29, 2022